{"id":"maoa","name":"MAO-A (MAOA)","symbol":"MAOA","route":"/targets/maoa/","asOf":"2026-11-03","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6833","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000189221","uniprot":"https://www.uniprot.org/uniprotkb/P21397/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P21397","open-targets":"https://platform.opentargets.org/target/ENSG00000189221","civic":"https://civicdb.org/genes/4128/summary","oncokb":"https://www.oncokb.org/gene/MAOA","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=MAOA","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=MAOA","depmap":"https://depmap.org/portal/gene/MAOA?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000189221-MAOA","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/4128","omim":"https://www.omim.org/entry/309850"}],"products":[{"id":"itr-251","name":"ITR-251","status":"phase-1","modality":"Small molecule","route":"/drugs/itr-251/"}],"trials":[{"id":"nct07870096","name":"ITR-251 in Patients With Advanced Solid Tumors","nct":"NCT07870096","phase":"1","status":"planned"}],"pathways":[],"companies":["iteria-biopharma"],"keyPapers":[],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}